NCT02287129 Evaluation for the Individualization of Therapy in Adenocarcinomas of the Gastroesophageal Junction Status COMPLETED Phase PHASE2
NCT02270606 Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer Status COMPLETED Phase PHASE1
NCT02250209 T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy Status UNKNOWN Phase PHASE2
NCT02246049 A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC Status COMPLETED Phase PHASE2
NCT02244632 Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02244489 Momelotinib Combined With Capecitabine and Oxaliplatin in Adults With Relapsed/Refractory Metastatic Pancreatic Ductal Adenocarcinoma Status TERMINATED Phase PHASE1
NCT02231723 A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT02216149 Effects of S-1 and Capecitabine on Coronary Artery Blood Flow Status TERMINATED Phase PHASE2
NCT02181218 Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas Status COMPLETED Phase PHASE1
NCT02177552 Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma Status UNKNOWN Phase PHASE2
NCT02172976 Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma Status COMPLETED Phase PHASE2/PHASE3
NCT02141295 A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer Status TERMINATED Phase PHASE2
NCT02129322 Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1 Status WITHDRAWN Phase PHASE2
NCT02121405 Randomized Trial of Primary Surgery Followed Selective Radiochemotherapy for Rectal Cancer With MRI Negative CRM Status SUSPENDED Phase PHASE3
NCT02119026 Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT02105350 A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer Status WITHDRAWN Phase PHASE1
NCT02077998 Oxaliplatin in Treating Patients With Metastatic Breast Cancer Status COMPLETED Phase EARLY_PHASE1
NCT02076594 Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer Status TERMINATED Phase PHASE3
NCT02071043 Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis Status COMPLETED Phase PHASE2